Back to search

Article

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia

2026-01-08

Abstract excerpt

Mutations in SET binding protein 1 ( SETBP1 ) are associated with an adverse prognosis in myeloid malignancies. These mutations stabilize SETBP1 protein, driving increased expression of a progenitor-associated gene expression program through incompletely described mechanisms. A proteomic screen revealed interactions between SETBP1 and members of the MYST acetyltransferase complexes, including the catalytic subuni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a046f1a9-9cba-585b-8f58-6cc697750e19
DOI
10.64898/2026.01.08.697228
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemiaDOI 10.64898/2026.01.08.697228
Select a neighboring publication to make it the new centre.